☰

Katherine J. Rowland, Ph.D. - Publications

Affiliations: 
2011 Physiology University of Toronto, Toronto, ON, Canada 
Area:
Physiology Biology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 El-Sehemy A, Selvadurai HJ, Ortin-Martinez A, Pokrajac NT, Mamatjan Y, Tachibana N, Rowland KJ, Lee L, Park NI, Aldape KD, Dirks P, Wallace VA. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and WNT. The Journal of Clinical Investigation. PMID 32182224 DOI: 10.1172/Jci128994  0.406
2019 Rajakulendran N, Rowland KJ, Selvadurai HJ, Ahmadi M, Park NI, Naumenko S, Dolma S, Ward RJ, So M, Lee L, MacLeod G, Pasiliao C, Brandon C, Clarke ID, Cusimano MD, et al. Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells. Genes & Development. PMID 30842215 DOI: 10.1101/Gad.321968.118  0.415
2019 Elsehemy AA, Selvadurai H, Ortin-Martinez A, Pokrajac N, Mamatjan Y, Rowland K, Aldape K, Dirks P, Wallace V. Abstract 4671: Novel biological roles of the atypical WNT ligand, Norrin, on glioblastoma stem cells segregate with ASCL1 expression Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4671  0.335
2018 Elsehemy AA, Selvadurai H, Rowland K, Dirks P, Wallace V. Abstract 1117: Norrin signaling is protumorigenic in glioblastoma progression Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1117  0.301
2016 Dolma S, Selvadurai HJ, Lan X, Lee L, Kushida M, Voisin V, Whetstone H, So M, Aviv T, Park N, Zhu X, Xu C, Head R, Rowland KJ, Bernstein M, et al. Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells. Cancer Cell. 29: 859-873. PMID 27300435 DOI: 10.1016/J.Ccell.2016.05.002  0.433
2016 Rajakulendran N, Selvadurai H, Rowland K, Park N, Batada N, Dirks P, Angers S. Abstract B14: Wnt signaling circuits in glioblastoma multiforme Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-B14  0.414
2015 Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, Holland D, Brubaker PL, Drucker DJ. GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7. Cell Metabolism. 21: 379-91. PMID 25738454 DOI: 10.1016/J.Cmet.2015.02.005  0.685
2014 Dong CX, Zhao W, Solomon C, Rowland KJ, Ackerley C, Robine S, Holzenberger M, Gonska T, Brubaker PL. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function. Endocrinology. 155: 370-9. PMID 24265452 DOI: 10.1210/En.2013-1871  0.656
2011 Rowland KJ, Trivedi S, Lee D, Wan K, Kulkarni RN, Holzenberger M, Brubaker PL. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion. Gastroenterology. 141: 2166-2175.e7. PMID 21925122 DOI: 10.1053/J.Gastro.2011.09.014  0.705
2011 Rowland KJ, Brubaker PL. The "cryptic" mechanism of action of glucagon-like peptide-2. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G1-8. PMID 21527727 DOI: 10.1152/Ajpgi.00039.2011  0.715
2011 Leen JL, Izzo A, Upadhyay C, Rowland KJ, Dubé PE, Gu S, Heximer SP, Rhodes CJ, Storm DR, Lund PK, Brubaker PL. Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts. Endocrinology. 152: 436-46. PMID 21159855 DOI: 10.1210/En.2010-0822  0.635
2011 Rowland KJ, Lee D, Wan K, Brubaker PL. Intestinal Epithelial Insulin-Like Growth Factor-1 Receptor Mediates Chronic Glucagon-Like Peptide-2-Induced Epithelial Proliferation and Associated Growth of the Crypt-Villus Unit Gastroenterology. 140: S-168-S-169. DOI: 10.1016/S0016-5085(11)60683-5  0.693
2009 Rowland KJ, Trivedi S, Brubaker PL. 867 The Intestinal Epithelial Insulin-Like Growth Factor-1 Receptor Is Required for Acute Intestinal Adaptive Growth Effects But Not Activation of Canonical Wnt Signaling By Glucagon-Like Peptide-2 Gastroenterology. 136: A-133. DOI: 10.1016/S0016-5085(09)60596-5  0.708
2008 Rowland KJ, Brubaker PL. Life in the crypt: a role for glucagon-like peptide-2? Molecular and Cellular Endocrinology. 288: 63-70. PMID 18403107 DOI: 10.1016/J.Mce.2008.02.014  0.683
2008 Dubé PE, Rowland KJ, Brubaker PL. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I. Endocrinology. 149: 291-301. PMID 17884945 DOI: 10.1210/En.2007-0561  0.668
Show low-probability matches.